台灣偏頭痛病患發生睡眠障礙之風險：一項全國性之世代研究

The risk of incident sleep disorder in migraine patients in Taiwan: a nationwide cohort study

10.6288/TJPH.201902_38(1).107092

李建瑩(CHIEN-YING LEE)；蔡雅芳(YA-FANG TSAI)；張雯婷(WEN-TING CHANG)；蔡東翰(TUNG-HAN TSAI)；黃光華(KUANG-HUA HUANG)

偏頭痛 ； 睡眠障礙 ； 用藥型態 ； 全民健保資料庫 ； 世代研究 ； migraine ； sleep disorder ； prescription patterns ； National Health Research Institutes Database ； cohort study

台灣公共衛生雜誌

38卷1期（2019 / 02 / 22）

81 - 91

繁體中文

目標：偏頭痛與睡眠障礙之相關性是複雜的，本研究探討偏頭痛與睡眠障礙之相關性，同時瞭解其他共病與偏頭痛之用藥是否會影響其相關性。方法：本研究為一回溯性世代研究，以承保抽樣歸人檔作為分析資料庫，以新發生之偏頭痛病患作為研究組，且排除曾出現睡眠障礙者，並利用傾向分數配對法，取得無偏頭痛之病患作為對照組。取得研究對象後，進一步控制相關變項，以Cox比例風險模式探討偏頭痛與發生睡眠障礙之相關性。本研究之控制變項為共病情況及偏頭痛之用藥型態。結果：偏頭痛患者之睡眠障礙發生率為6.86%。偏頭痛患者相較於無偏頭痛患者，其發生睡眠障礙之風險比為2.71倍（95% CI=2.50-2.94）。高血壓患者（HR=1.45; 95% CI=1.29-1.64）、重鬱症（單純發作）患者（HR=1.94; 95% CI=1.29-2.92）與精神官能性憂鬱症患者（HR=1.61; 95% CI=1.23-2.11），皆有較高之發生睡眠障礙之風險比。偏頭痛用藥與睡眠障礙則無相關性。結論：偏頭痛與發生睡眠障礙確實具有相關性，高血壓疾病、重鬱症（單純發作）及精神官能性憂鬱症，亦為睡眠障礙之危險因子。

Objectives: The correlation between migraine and sleep disorders is complex and may be causal in nature. This study investigated the correlation between migraine and sleep disorders and discussed whether other comorbidities or prescription patterns influence their relevance. Methods: This retrospective cohort study used data from the Longitudinal Health Insurance Database of Taiwan. The study subjects were patients with new-onset migraine who had not been diagnosed as having a sleep disorder prior to migraine diagnosis. To avoid selection bias, we applied propensity score matching to select patients without migraine as the control group. We used the Cox proportional hazard model to analyze differences in the risk of sleep disorder among patients with migraine after controlling for related variables, including comorbidities and migraine prescription patterns. Results: The rate of incident sleep disorders was 6.86% in patients with migraine. The hazard ratio (HR) in patients with migraine was higher than that in patients without migraine (HR = 2.71; 95% confidence interval [CI] = 2.50-2.94). Patients with hypertension (HR = 1.45; 95% CI = 1.29-1.64), major depression (single episode) (HR = 2.38; 95% CI = 1.47-3.84), or neurotic depression (HR = 1.93; 95% CI = 1.41-2.64) had a higher risk of sleep disorders. Furthermore, migraine medication was not related to sleep disorders. Conclusions: Patients with migraine have a higher risk of sleep disorders than do those without migraine. The rate of sleep disorders is highest in patients with hypertension, major depression (single episode), or neurotic depression.

1. Ahn, AH,Goadsby, PJ(2013).Migraine and sleep: new connections.Cerebrum,2013,15.
2. Angriman, M,Cortese, S,Bruni, O(2017).Somatic and neuropsychiatric comorbidities in pediatric restless legs syndrome: a systematic review of the literature.Sleep Med Rev,34,34-45.
3. Ashina, S,Serrano, D,Lipton, RB(2012).Depression and risk of transformation of episodic to chronic migraine.J Headache Pain,13,615-624.
4. Bartleson, JD,Cutrer, FM(2010).Migraine update. Diagnosis and treatment.Minn Med,93,36-41.
5. Broner, SW,Bobker, S,Klebanoff, L(2017).Migraine in women.Semin Neurol,37,601-610.
6. Bruti, G,Magnotti, MC,Iannetti, G(2012).Migraine and depression: bidirectional co-morbidities?.Neurol Sci,33,S107-S109.
7. Burch, RC,Loder, S,Loder, E,Smitherman, TA(2015).The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies.Headache,55,21-34.
8. Cameron, C,Kelly, S,Hsieh, SC(2015).Triptans in the acute treatment of migraine: a systematic review and network meta-analysis.Headache,55(Suppl 4),221-235.
9. Cevoli, S,Giannini, G,Favoni, V,Pierangeli, G,Cortelli, P(2012).Migraine and sleep disorders.Neurol Sci,33(Suppl 1),S43-S46.
10. Chi, MJ,Lee, CY,Wu, SC(2011).The prevalence of chronic conditions and medical expenditures of the elderly by chronic condition indicator (CCI).Arch Gerontol Geriatr,52,284-289.
11. Chu, CC,Liu, CJ,Shih, CM,Kung, PT,Tsai, YS,Tsai, WC(2015).The risk and related factors for readmission to an ICU within 7 days in Mechanically Ventilated Subjects -- a nationwide population-based cohort study.Respir Care,60,1786-1795.
12. Evers, S.(2010).Sleep and headache: the biological basis.Headache,50,1246-1251.
13. Fernandez-de-Las-Penas, C,Fernandez-Munoz, JJ,Palacios-Cena, M,Paras-Bravo, P,Cigaran-Mendez, M,Navarro-Pardo, E(2018).Sleep disturbances in tension-type headache and migraine.Ther Adv Neurol Disord,11,1756285617745444.
14. Hamel, E(2007).Serotonin and migraine: biology and clinical implications.Cephalalgia,27,1293-1300.
15. Hershey, AD(2010).Current approaches to the diagnosis and management of paediatric migraine.Lancet Neurol,9,190-204.
16. Lee, CF,Lin, KY,Lin, MC,Lin, CL,Chang, SN,Kao, CH(2014).Sleep disorders increase the risk of burning mouth syndrome: a retrospective population-based cohort study.Sleep Med,15,1405-1410.
17. Lin, YK,Lin, GY,Lee, JT(2016).Associations between sleep quality and migraine frequency: a cross-sectional case-control study.Medicine,95,e3554.
18. Loder, E,Burch, R,Rizzoli, P(2012).The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines.Headache,52,930-945.
19. McIntire, RK,Nelson, AA,Macy, JT,Seo, DC,Kolbe, LJ(2015).Secondhand smoke exposure and other correlates of susceptibility to smoking: a propensity score matching approach.Addict Behav,48,36-43.
20. Modgill, G,Jette, N,Wang, JL,Becker, WJ,Patten, SB(2012).A population-based longitudinal community study of major depression and migraine.Headache,52,422-432.
21. Nappi, RE,Sances, G,Detaddei, S,Ornati, A,Chiovato, L,Polatti, F(2009).Hormonal management of migraine at menopause.Menopause Int,15,82-86.
22. Parsons, LS(2001).Reducing bias in a propensity score matched-pair sample using greedy matching techniques.Proceedings of the Twenty-Sixth Annual SAS Users Group International Conference,Long Beach, California:
23. Piane, M,Lulli, P,Farinelli, I(2007).Genetics of migraine and pharmacogenomics: some considerations.J Headache Pain,8,334-339.
24. Rizzoli, PB(2012).Acute and preventive treatment of migraine.Continuum,18,764-782.
25. Silberstein, SD,Holland, S,Freitag, F(2012).Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.Neurology,78,1337-1345.
26. Stovner, LJ,Nichols, E,Steiner, TJ(2018).Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.Lancet Neurol,17,954-976.
27. Uhlig, BL,Engstrøm, M,Ødegård, SS,Hagen, KK,Sand, T(2014).Headache and insomnia in population-based epidemiological studies.Cephalalgia,34,745-751.
28. Woolley, JM,Bonafede, MM,Maiese, BA,Lenz, RA(2017).Migraine prophylaxis and acute treatment patterns among commercially insured patients in the United States.Headache,57,1399-1408.
29. 衛生福利部資料科學中心：資料庫操作手冊。https://dep.mohw.gov.tw/DOS/cp-2498-37767-113.html。引用2018/12/20。 Health and Welfare Data Science Center. Manual of Health and Welfare Database. Available at: https://dep.mohw.gov.tw/DOS/cp-2498-37767-113.html. Accessed December 20, 2018. [In Chinese]